FilingReader Intelligence
Alembic Pharma gets US approval for acne cream
August 15, 2025 at 04:19 PM UTC•By FilingReader AI
Alembic Pharmaceuticals received US FDA approval for Tretinoin Cream USP, 0.025%, a generic equivalent to Retin-A Cream for treating acne.
The market for the product was worth $94m in the twelve months ending June 2025. The approval brings Alembic's total US drug approvals to 224.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
BSE:APLLTD•Bombay Stock Exchange
News Alerts
Get instant email alerts when ALEMBIC PHARMACEUTICALS publishes news
Free account required • Unsubscribe anytime